Combination therapy in cholesterol reduction: focus on ezetimibe and statins

References

• AltmannSWDavisHRJrZhuLJNiemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorptionScience20043031201414976318
   PubMed Web of Science ®Google Scholar
• AnonThe Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart diseaseJAMA1984251351646361299
   PubMed Web of Science ®Google Scholar
• AnonRandomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)Lancet1994344138397968073
   PubMed Web of Science ®Google Scholar
• BallantyneCAbateNZhongYDose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia. the Vytorin Versus Atorvastatin (VYVA Study)Am Heart J20051494647315864235
   PubMed Web of Science ®Google Scholar
• BallantyneCSosefFDuffieldEEfficacy and safety of rosuvastatin plus ezetimibe in high-risk patients: results from the EXPLORER studyAtherosclerosis Supplement20067552 abstract
   Web of Science ®Google Scholar
• BallantyneCMBlazingMAKingTREfficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemiaAm J Cardiol20049314879415194018
   PubMed Web of Science ®Google Scholar
• BallantyneCMHouriJNotarbartoloAEffect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trialCirculation200310724091512719279
   PubMed Web of Science ®Google Scholar
• BrewerHBJrSantamarina-FojoSNew insights into the role of the adenosine triphosphate-binding cassette transporters in high-density lipoprotein metabolism and reverse cholesterol transportAm J Cardiol2003913E11E
   PubMed Web of Science ®Google Scholar
• CarsteaEDMorrisJAColemanKGNiemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasisScience1997277228319211849
   PubMed Web of Science ®Google Scholar
• CastelliWPAndersonKWilsonPWLipids and risk of coronary heart disease. The Framingham StudyAnn Epidemiol199222381342260
   PubMedGoogle Scholar
• CatapanoALDavidsonMHBallantyneCMLipid-altering efficacy on the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patientsCurr Med Res Opin20062220415317022864
   PubMed Web of Science ®Google Scholar
• CollinsRArmitageJParishSEffects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditionsLancet20043637576715016485
   PubMed Web of Science ®Google Scholar
• CookRPCookRPCholesterol. Distribution of sterols in organisms and in tissuesCholesterol. Chemistry, biochemistry, and pathology1958New YorkAcademic Press14580
   Google Scholar
• DavidsonMHRobinsonJGSafety of aggressive lipid managementJ Am Coll Cardiol20074917536217466224
   PubMed Web of Science ®Google Scholar
• DaviesJPIoannouYATopological analysis of Niemann-Pick C1 protein reveals that the membrane orientation of the putative sterol-sensing domain is identical to those of 3-hydroxy-3-methylglutaryl-CoA reductase and sterol regulatory element binding protein cleavage-activating proteinJ Biol Chem2000275243677410821832
   PubMed Web of Science ®Google Scholar
• DenkeMPearsonTMcBridePEzetimibe added to ongoing statin therapy improves LDL-C goal attainment and lipid profile in patients with diabetes or metabolic syndromeDiabetes Vasc Dis Res2006393102
   PubMedGoogle Scholar
• DietschyJMTurleySDSpadyDKRole of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humansJ Lipid Res1993341637598245716
   PubMed Web of Science ®Google Scholar
• DownsJRClearfieldMTyrolerHAAir Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatinAm J Cardiol2001871074911348605
   PubMed Web of Science ®Google Scholar
• DujovneCAEttingerMPMcNeerJFEfficacy and safety of potent new selective cholesterol absorbtion inhibitor, ezetimibe in patients with primary hypercholesterolemiaAm J Cardiol2002901092712423709
   PubMed Web of Science ®Google Scholar
• FarnierMRothEGil-ExtremeraBEzetimibe/Simvastatin + Fenofibrate Study GroupEfficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemiaAm Heart J2007153335.e1817239698
   PubMed Web of Science ®Google Scholar
• FeldmanTKorenMInsullWJrTreatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goalsAm J Cardiol2004931481615194017
   PubMed Web of Science ®Google Scholar
• FoleyKASimpsonRJJrCrouseJRIIIEffectiveness of statin titration on low-density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic eventsAm J Cardiol200392798112842255
   PubMed Web of Science ®Google Scholar
• FrickMHEloOHaapaKHelsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart diseaseN Engl J Med19873171237453313041
   PubMed Web of Science ®Google Scholar
• GagneCBaysHEWeissSREfficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemiaAm J Cardiol20029010849112423708
   PubMed Web of Science ®Google Scholar
• GagneCBaysHEWeissSREfficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemiaAm J Cardiol20029010849112423708
   PubMed Web of Science ®Google Scholar
• Garcia-CalvoMThe target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)Proc Natl Acad Sci USA20051028132715928087
   PubMed Web of Science ®Google Scholar
• GoettschWGYinDDAlemaoEStatins are less effective in common daily practice among patients with hypercholesterolemia: the REALITY-PHARMO studyCurr Med Res Opin20042010253315265247
   PubMed Web of Science ®Google Scholar
• GoldbergRBGuytonJRMazzoneTEzetimibe/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the Vytal studyMayo Clin Proc20068115798817165637
   PubMed Web of Science ®Google Scholar
• GoldsteinJLBrownMSRegulation of mevalonate pathwayNature1990343425301967820
   PubMed Web of Science ®Google Scholar
• GrundySMCleemanJIMerzCNImplications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesJ Am Coll Cardiol2004447203215358046
   PubMed Web of Science ®Google Scholar
• IllingworthDRDuellPBConnorWEFeligPBaxterJDFrohmanLADisorders of lipid metabolismEndocrinology and metabolism1995New YorkMcGraw-Hill1315403
   Google Scholar
• KerznerBCorbelliJSharpSEfficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemiaAm J Cardiol2003914182412586255
   PubMed Web of Science ®Google Scholar
• KosoglouTStatkevichPJohnson-LevonasAOEzetimibe: a review of its metabolism, pharmacokinetics and drug interactionsClin Pharmacokinet2005444679415871634
   PubMed Web of Science ®Google Scholar
• LammertFWangDQHNew insights into the genetic regulation of intestinal cholesterol absorbtionGastroenterology20051297183416083725
   PubMed Web of Science ®Google Scholar
• LavoieMAEzetimibe and cholesterol absorptionCan J Clin Pharmacol200310Suppl A7A12A
   PubMedGoogle Scholar
• LeibovitzEGavishDBitzurREfficacy and safety of rosuvastatin-ezetimibe combination for the treatment of severe hypercholesterolemiaAtheroscler Suppl20067554 abstract
   Web of Science ®Google Scholar
• LevyESpahisSSinnetDIntestinal cholesterol transport proteins: an update and beyondCurr Opin Lipidol2007183101817495606
   PubMed Web of Science ®Google Scholar
• ManninenVEloMOFrickMHLipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart StudyJAMA1988260641513164788
   PubMed Web of Science ®Google Scholar
• McKenneyJMFarnierMLoKWSafety and efficacy of long-term co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemiaJ Am Coll Cardiol2006471584716630994
   PubMed Web of Science ®Google Scholar
• MelaniLMillsRHassmanDEfficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: a prospective, randomized, double-blind trialEur Heart J2003247172812713766
   PubMed Web of Science ®Google Scholar
• NealRCJonesPHLipid-lowering: can ezetimibe help close the treatment gap?Cleve Clin J Med2003707778314518572
   PubMed Web of Science ®Google Scholar
• ParkerRALarkRWSitSYSelective inhibition of cholesterol synthesis in liver versus extrahepatic tissues by HMG-CoA reductase inhibitorsJ Lipid Res1990311271822401858
   PubMed Web of Science ®Google Scholar
• PatrickJEKosoglouTStauberKLDisposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjectsDrug Metab Dispos2002129174854
   Google Scholar
• PearsonTDenkeMMcBridePEzetimibe added to statin therapy reduces LDL-C and improves goal attainment in patients with hypercholesterolemia2004American College of Cardiology 53rd Annual MeetingMarch 7-10, 2004New Orleans abstract
   Google Scholar
• RepaJJMangelsdorfDJThe liver X receptor gene team: potential new players in atherosclerosisNat Med200281243812411951
   PubMed Web of Science ®Google Scholar
• RepaJJTurleySDLobaccaroJARegulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimersScience20002891524910968783
   PubMed Web of Science ®Google Scholar
• RussellDWNuclear orphan receptors control cholesterol catabolismCell1999975394210367881
   PubMed Web of Science ®Google Scholar
• SalenGTintGSSheferSIncreased sitosterol absorption is offset by rapid elimination to prevent accumulation in heterozygotes with sitosterolemiaArterioscler Thromb19991256381576118
   PubMedGoogle Scholar
• SeedorfUEngelTLuekenACholesterol absorption inhibitor Ezetimibe blocks uptake of oxidized LDL in human macrophagesBiochem Biophys Res Commun200432013374115303279
   PubMed Web of Science ®Google Scholar
• ShepherdJCobbeSMFordIPrevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study GroupN Engl J Med1995333130177566020
   PubMed Web of Science ®Google Scholar
• ShepherdJLipids in health and diseaseBiochem Soc Trans2004321051615506961
   PubMed Web of Science ®Google Scholar
• StamlerJWentworthDNeatonJDIs relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)JAMA1986256282383773199
   PubMed Web of Science ®Google Scholar
• SteinbergDWitztumJLLipoproteins and atherogenesis. Current conceptsJAMA19902643047522243434
   PubMed Web of Science ®Google Scholar
• SviridovDDSafonovaIGPavlovMYInhibition of cholesterol synthesis by lovastatin tested on six human cell types in vitroLipids19902517792159099
   PubMed Web of Science ®Google Scholar
• Van HeekMFarleyCComptonDSComparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663Br J Pharmacol200012917485410780982
   PubMed Web of Science ®Google Scholar
• WangDQHRegulation of intestinal cholesterol absorbtionAnnu Rev Physiol2007692214817002594
   PubMed Web of Science ®Google Scholar
• WilsonPWGarrisonRJCastelliWPPrevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterolsAm J Cardiol198046649547416024
   PubMed Web of Science ®Google Scholar